Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice cold feet, or a general feeling of coldness in their extremities, after starting Wegovy. This is a reported experience during semaglutide treatment, and while it isn't listed as a common side effect in the official prescribing information, there are plausible physiological reasons it happens — particularly in the first weeks of treatment. Here's what the clinical picture actually tells us, and what's worth discussing with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. That kind of sustained calorie deficit has predictable downstream effects on thermoregulation. When the body is running at a lower energy intake, it produces less metabolic heat. Blood flow to peripheral tissues, including the feet, can reduce as the body prioritises warmth for the core organs. This isn't unique to semaglutide (it's a pattern seen across calorie-restricted weight-loss approaches) but the appetite suppression Wegovy produces can make the deficit more pronounced than people expect.
Semaglutide also slows gastric emptying, which affects how quickly nutrients enter the bloodstream. In the early weeks, before the body adjusts, energy availability can dip in ways that amplify that cold feeling, and you can read more about how semaglutide affects cold hands and feet in people going through this process. Most people find this settles as they stabilise at a given dose. If you're curious about the wider range of temperature-related experiences people report, feeling cold on Wegovy more generally covers the picture in more detail.
The NHS medicines page for semaglutide lists the common and serious side effects of Wegovy in plain language. Cold extremities don't appear there as a named common side effect. That matters, because it means you shouldn't automatically assume your cold feet are a direct pharmacological effect of semaglutide in the way that nausea or diarrhoea would be.
There are other explanations worth considering. Raynaud's phenomenon (episodic narrowing of small blood vessels in the fingers and toes triggered by cold or stress) becomes more noticeable during periods of significant physical change. Anaemia, which can develop if dietary protein and iron intake drop during weight loss, also causes cold extremities. Thyroid changes, peripheral arterial disease, and nerve-related conditions are all possibilities that a GP can check quickly. The point isn't to alarm; it's to say that cold and uncomfortable feet specifically on Wegovy can have several concurrent causes, and a single conversation with a clinician tends to resolve most of the uncertainty. Worth checking.
Most reports of cold feet during semaglutide treatment are bilateral (both feet), mild, and tied to early dose stages or periods of very low food intake, and our page on whether you feel cold on Wegovy explores why some people are more affected than others at these stages. These tend to improve without intervention once eating patterns stabilise and the body acclimates to the new metabolic baseline.
Some presentations are different and need faster attention. If one foot is significantly colder than the other, if the skin is pale, blue or mottled, if there is pain at rest or ulcers that won't heal, or if the coldness appeared suddenly alongside chest pain or breathlessness, get medical assessment promptly. These patterns can indicate circulatory problems unrelated to weight-loss treatment that happen to have surfaced at the same time.
The MHRA's Yellow Card scheme exists precisely for experiences like this: suspected side effects that don't fit the familiar list. Reporting through Yellow Card helps regulators identify signals that weren't captured in trials, and it's open to patients as well as clinicians. If your cold feet feel like a reaction to Wegovy, reporting it is genuinely useful, not just a box-ticking exercise.
If cold feet are making things uncomfortable, a few practical adjustments are worth trying before escalating. Ensuring adequate protein intake (lean meat, fish, eggs, legumes) helps preserve muscle and supports circulation. Staying well hydrated matters more than many people realise during active weight loss, dehydration concentrates blood and makes peripheral circulation sluggish. Gentle movement, even short walks, keeps blood moving to the extremities. Wool socks are not a glamorous intervention, but they work.
On the clinical side, your prescriber can review whether the current dose pace is right for you. Slowing titration is sometimes appropriate when side effects are affecting quality of life, and our guide to semaglutide and feeling cold covers what to discuss with your prescriber if this is becoming a persistent issue. For people considering their options or wondering whether Wegovy is the right treatment for their situation, our team at nume... the nume clinical team reviews each case individually, and there's no algorithm making that call. You can explore the full range of weight-loss treatment options we offer, or read more about how semaglutide works as a treatment. When you're ready, check your eligibility with a free consultation, a prescriber will look at your full picture, including any symptoms you're managing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.